MDGL: Madrigal Pharmaceuticals Inc. Stocks News on December 22, 2024

MDGL

Simply Wall St.

4 days ago

Madrigal Pharmaceuticals, Inc.'s (NASDAQ:MDGL) Profit Outlook

Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities

MDGL

TipRanks

16 days ago

Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities

MDGL

MT Newswires

17 days ago

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,135,122, According to a Recent SEC Filing

3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

MDGL

Motley Fool

a month ago

3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move

MDGL

Zacks

a month ago

Madrigal (MDGL) Just Flashed Golden Cross Signal: Do You Buy?

MDGL

Insider Monkey

a month ago

Why Is Madrigal Pharmaceuticals, Inc. (MDGL) Among the Worst Performing Biotech Stocks in 2024?

The first MASH drug could open the door for others — including GLP-1s

MDGL

Pharma Voice

a month ago

The first MASH drug could open the door for others — including GLP-1s

John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC

MDGL

GuruFocus.com

a month ago

John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC

MDGL

Zacks

a month ago

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance

1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

MDGL

Motley Fool

a month ago

1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More

5 Small Drug Stocks to Buy as Trump Gets Re-Elected

MDGL

Zacks

a month ago

5 Small Drug Stocks to Buy as Trump Gets Re-Elected

3 High Growth Tech Stocks Leading The US Market

MDGL

Simply Wall St.

a month ago

3 High Growth Tech Stocks Leading The US Market

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

MDGL

GlobeNewswire

2 months ago

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

MDGL

MT Newswires

2 months ago

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,504,703, According to a Recent SEC Filing

MDGL

MT Newswires

2 months ago

B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $236 From $194, Maintains Neutral Rating

Madrigal Stock Soars 23% as NASH Drug Rezdiffra Crushes Expectations

MDGL

GuruFocus.com

2 months ago

Madrigal Stock Soars 23% as NASH Drug Rezdiffra Crushes Expectations

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH

MDGL

TipRanks

2 months ago

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH

MDGL

Simply Wall St.

2 months ago

Analysts Just Made A Notable Upgrade To Their Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Forecasts

Madrigal Pharmaceuticals stock jumps on MASH drug hopes

MDGL

Yahoo Finance Video

2 months ago

Madrigal Pharmaceuticals stock jumps on MASH drug hopes

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

MDGL

Investor's Business Daily

2 months ago

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

MDGL

MT Newswires

2 months ago

UBS Adjusts Price Target on Madrigal Pharmaceuticals to $441 From $411, Maintains Buy Rating

Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up

MDGL

Zacks

2 months ago

Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock Up

MDGL

GuruFocus.com

2 months ago

Madrigal Pharmaceuticals Inc (MDGL) Q3 2024 Earnings Call Highlights: Strong Sales and ...

MDGL

MT Newswires

2 months ago

Sector Update: Health Care

MDGL

MT Newswires

2 months ago

Madrigal Pharmaceuticals' Shares Rise After Reporting Narrower Q3 Loss

MDGL

Associated Press Finance

2 months ago

Madrigal: Q3 Earnings Snapshot

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

MDGL

GlobeNewswire

2 months ago

Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®

MDGL

GlobeNewswire

2 months ago

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®

Madrigal Pharmaceuticals enrols patients in Phase III trial of NASH cirrhosis drug

MDGL

Clinical Trials Arena

2 months ago

Madrigal Pharmaceuticals enrols patients in Phase III trial of NASH cirrhosis drug

Madrigal Pharmaceuticals Completes Enrollment of Clinical Outcomes Study of Resmetirom in Patients with Compensated NASH/MASH Cirrhosis

MDGL

GlobeNewswire

2 months ago

Madrigal Pharmaceuticals Completes Enrollment of Clinical Outcomes Study of Resmetirom in Patients with Compensated NASH/MASH Cirrhosis

Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024

MDGL

GlobeNewswire

2 months ago

Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 2024

MDGL

Insider Monkey

2 months ago

Madrigal Pharmaceuticals (MDGL): Leading the NASH Treatment Revolution with Rezdiffra

High Growth Tech Stocks To Watch In October 2024

MDGL

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In October 2024

Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference

MDGL

GlobeNewswire

3 months ago

Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference

Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development

MDGL

GlobeNewswire

3 months ago

Madrigal Pharmaceuticals Appoints Dr. Michael R. Charlton as Senior Vice President, Clinical Development

Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom)

MDGL

GlobeNewswire

3 months ago

Madrigal Pharmaceuticals Announces Publication of Positive Health-Related Quality of Life Results from the Phase 3 MAESTRO-NASH Trial of Rezdiffra™ (resmetirom)

MDGL

Insider Monkey

3 months ago

Is Madrigal Pharmaceuticals, Inc. (MDGL) the Best Guru Stock To Buy Now?

MDGL

MT Newswires

3 months ago

Madrigal Pharmaceuticals Insider Sold Shares Worth $1,551,490, According to a Recent SEC Filing

Exploring 3 High Growth Tech Stocks in the United States

MDGL

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks in the United States

Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

MDGL

GlobeNewswire

4 months ago

Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Is Madrigal Pharmaceuticals Stock a Buy?

MDGL

Motley Fool

4 months ago

Is Madrigal Pharmaceuticals Stock a Buy?

John Paulson's Strategic Exits and Key Investments in Q2 2024: Spotlight on Newmark Group Inc

MDGL

GuruFocus.com

4 months ago

John Paulson's Strategic Exits and Key Investments in Q2 2024: Spotlight on Newmark Group Inc

This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock

MDGL

Motley Fool

4 months ago

This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock

Madrigal plans to solidify Rezdiffra’s position in MASH despite start being slower than expected

MDGL

Pharmaceutical Technology

4 months ago

Madrigal plans to solidify Rezdiffra’s position in MASH despite start being slower than expected

MDGL

MT Newswires

4 months ago

B. Riley Adjusts Price Target on Madrigal Pharmaceuticals to $194 From $200, Maintains Neutral Rating

MDGL

Thomson Reuters StreetEvents

4 months ago

Q2 2024 Madrigal Pharmaceuticals Inc Earnings Call

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

MDGL

Investor's Business Daily

4 months ago

Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'

MDGL

Zacks

4 months ago

Madrigal (MDGL) Tops on Q2 Earnings, NASH Drug Drives Top Line

MDGL

MT Newswires

4 months ago

Madrigal Pharmaceuticals Reports Q2 Revenue as Loss Widens; Shares Gain Pre-Bell

MDGL

Associated Press Finance

4 months ago

Madrigal: Q2 Earnings Snapshot

Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates

MDGL

GlobeNewswire

4 months ago

Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates

Madrigal’s MASH drug launch gets off to a fast start

MDGL

BioPharma Dive

4 months ago

Madrigal’s MASH drug launch gets off to a fast start

Is It Too Late to Buy Madrigal Pharmaceuticals Stock?

MDGL

Motley Fool

5 months ago

Is It Too Late to Buy Madrigal Pharmaceuticals Stock?

Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel

MDGL

GlobeNewswire

5 months ago

Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel

Top Growth Stocks With High Insider Ownership In US For August 2024

MDGL

Simply Wall St.

5 months ago

Top Growth Stocks With High Insider Ownership In US For August 2024

Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024

MDGL

GlobeNewswire

5 months ago

Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024

MDGL

MT Newswires

5 months ago

JMP Securities Raises Price Target on Madrigal Pharmaceuticals to $385 From $381, Maintains Market Outperform Rating

Unveiling Three US Growth Companies With High Insider Ownership

MDGL

Simply Wall St.

6 months ago

Unveiling Three US Growth Companies With High Insider Ownership

Is Madrigal Pharmaceuticals a Millionaire Maker?

MDGL

Motley Fool

6 months ago

Is Madrigal Pharmaceuticals a Millionaire Maker?

MDGL

MT Newswires

6 months ago

Cantor Fitzgerald Starts Madrigal Pharmaceuticals With Neutral Rating

MDGL

Motley Fool

6 months ago

Is Madrigal Pharmaceuticals Stock a Buy?

Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

MDGL

Motley Fool

6 months ago

Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

Where Will Madrigal Pharmaceuticals Be in 3 Years?

MDGL

Motley Fool

6 months ago

Where Will Madrigal Pharmaceuticals Be in 3 Years?

Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade

MDGL

Investor's Business Daily

6 months ago

Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade

Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

MDGL

Motley Fool

6 months ago

Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

Bang Energy Announces Monumental Partnership with Star Streaming Group AMP

MDGL

PR Newswire

6 months ago

Bang Energy Announces Monumental Partnership with Star Streaming Group AMP

Exclusive-IPOs of Walmart's Flipkart, PhonePe could take couple of years, Walmart exec says

MDGL

Reuters

6 months ago

Exclusive-IPOs of Walmart's Flipkart, PhonePe could take couple of years, Walmart exec says

Broadcom is the 'best AI story' after Nvidia: Analyst

MDGL

Yahoo Finance Video

6 months ago

Broadcom is the 'best AI story' after Nvidia: Analyst

Slapstick platformer Thank Goodness You're Here! arrives August 1

MDGL

Engadget

6 months ago

Slapstick platformer Thank Goodness You're Here! arrives August 1

Earnings Calendar, Analyst Estimates And Stocks To Watch

MDGL

Investor's Business Daily

6 months ago

Earnings Calendar, Analyst Estimates And Stocks To Watch

Gross rescues Germany with last-gasp winner against Greece

MDGL

AFP

6 months ago

Gross rescues Germany with last-gasp winner against Greece

MDGL

Daily Times-Call, Longmont, Colo.

6 months ago

Local News | Longmont Community Justice Partnership marks 30 years of building connections

Tesla shareholders to vote on $56B Musk pay package

MDGL

Yahoo Finance Video

6 months ago

Tesla shareholders to vote on $56B Musk pay package

MDGL

MT Newswires

7 months ago

Madrigal Pharmaceuticals Reports Positive Results in New Analysis of Phase 3 Trial of NASH Drug Rezdiffra

Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress

MDGL

GlobeNewswire

7 months ago

Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

MDGL

Investor's Business Daily

7 months ago

Madrigal, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

MDGL

Benzinga

7 months ago

What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?

Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

MDGL

Investor's Business Daily

7 months ago

Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH

Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

MDGL

GlobeNewswire

7 months ago

Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) and Health Economics Outcomes Research Abstracts in NASH/MASH at the EASL Congress

MDGL

GlobeNewswire

7 months ago

Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) and Health Economics Outcomes Research Abstracts in NASH/MASH at the EASL Congress

MDGL

GuruFocus.com

7 months ago

Insider Sale at Madrigal Pharmaceuticals Inc (MDGL): Senior VP, Chief Pharmaceutical ...

MDGL

Motley Fool

7 months ago

Is Madrigal Pharmaceuticals Stock a Buy?

3 High Insider Ownership US Stocks With Up To 55% Revenue Growth

MDGL

Simply Wall St.

7 months ago

3 High Insider Ownership US Stocks With Up To 55% Revenue Growth

MDGL

MT Newswires

7 months ago

Madrigal Pharmaceuticals Insider Sold Shares Worth $4,787,404, According to a Recent SEC Filing

John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent Role

MDGL

GuruFocus.com

7 months ago

John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent Role

MDGL

MT Newswires

7 months ago

B. Riley Cuts Madrigal Pharmaceuticals' Price Target to $200 From $270, Keeps Neutral Rating

MDGL

MT Newswires

7 months ago

UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating

MDGL

Insider Monkey

7 months ago

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q1 2024 Earnings Call Transcript

MDGL

GuruFocus.com

7 months ago

Madrigal Pharmaceuticals Inc (MDGL) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

MDGL

MT Newswires

8 months ago

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MDGL

GuruFocus.com

8 months ago

Madrigal Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Rezdiffra Launch

MDGL

MT Newswires

8 months ago

Madrigal Pharmaceuticals Q1 Loss Widens; Shares Fall Pre-Bell

MDGL

Associated Press Finance

8 months ago

Madrigal: Q1 Earnings Snapshot

Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

MDGL

GlobeNewswire

8 months ago

Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

Madrigal Statement on the Passing of Dr. Stephen Harrison

MDGL

GlobeNewswire

8 months ago

Madrigal Statement on the Passing of Dr. Stephen Harrison

Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024

MDGL

GlobeNewswire

8 months ago

Madrigal Pharmaceuticals to Release First-Quarter 2024 Financial Results and Host Webcast on May 7, 2024

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

MDGL

GlobeNewswire

8 months ago

Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Latest Insider Selling in April 2024: 10 Stocks to Watch

MDGL

Insider Monkey

8 months ago

Latest Insider Selling in April 2024: 10 Stocks to Watch

Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis

MDGL

GlobeNewswire

8 months ago

Madrigal Pharmaceuticals Announces U.S. Availability of Rezdiffra™ (resmetirom) for the Treatment of Patients with Noncirrhotic NASH with Moderate to Advanced Liver Fibrosis

Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

MDGL

Motley Fool

9 months ago

Latest Madrigal Pharmaceuticals Inc. (MDGL) News on December 22, 2024

Share on Social Networks: